Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 213

1.

[High sensitivity T troponin and CA-125 as prognostic biomarkers in patients with end stage renal disease in hemodialysis].

Moreno JS, Lépori AJ, Novoa P, De Elia R, Guglielmone R, Bono JP.

Rev Fac Cien Med Univ Nac Cordoba. 2016;73(1):8-14. Spanish.

PMID:
27419890
2.

Association of NTproBNP and cTnI with outpatient sudden cardiac death in hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study.

Kruzan RM, Herzog CA, Wu A, Sang Y, Parekh RS, Matsushita K, Hwang S, Cheng A, Coresh J, Powe NR, Shafi T.

BMC Nephrol. 2016 Feb 20;17:18. doi: 10.1186/s12882-016-0230-x.

3.

Prognostic Value of Serial Changes in High-Sensitivity Cardiac Troponin I and T over 3 Months Using Reference Change Values in Hemodialysis Patients.

Sandoval Y, Herzog CA, Love SA, Cao J, Hu Y, Wu AH, Gilbertson D, Brunelli SM, Young A, Ler R, Apple FS.

Clin Chem. 2016 Apr;62(4):631-8. doi: 10.1373/clinchem.2015.251835.

PMID:
26847217
4.

Serum cardiac troponin T and effective blood flow in stable extracorporeal dialysis patients.

Grzegorzewska AE, Cieszyński K, Niepolski L, Kaczmarek A, Sowińska A.

Int Urol Nephrol. 2016 Mar;48(3):419-29. doi: 10.1007/s11255-015-1165-z.

5.

Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice.

Fahim MA, Hayen AD, Horvath AR, Dimeski G, Coburn A, Tan KS, Johnson DW, Craig JC, Campbell SB, Hawley CM.

Clin Chem Lab Med. 2016 May;54(5):e149-50. doi: 10.1515/cclm-2015-0998. No abstract available.

PMID:
26562041
6.

Which Biomarker is the Best for Predicting Mortality in Incident Peritoneal Dialysis Patients: NT-ProBNP, Cardiac TnT, or hsCRP?: A Prospective Observational Study.

Oh HJ, Lee MJ, Kwon YE, Park KS, Park JT, Han SH, Yoo TH, Kim YL, Kim YS, Yang CW, Kim NH, Kang SW.

Medicine (Baltimore). 2015 Nov;94(44):e1636. doi: 10.1097/MD.0000000000001636.

7.

Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice.

Mbagaya W, Luvai A.

Clin Chem Lab Med. 2016 May;54(5):e147. doi: 10.1515/cclm-2015-0885. No abstract available.

PMID:
26495930
8.

Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease.

Buiten MS, de Bie MK, Rotmans JI, Dekker FW, van Buren M, Rabelink TJ, Cobbaert CM, Schalij MJ, van der Laarse A, Jukema JW.

PLoS One. 2015 Aug 3;10(8):e0134245. doi: 10.1371/journal.pone.0134245.

9.

Cardiac Troponin T and Hydration Status as Prognostic Markers in Hemodialysis Patients.

Hoppe K, Schwermer K, Klysz P, Radziszewska D, Sawatiuk P, Baum E, Kaczmarek J, Roszak M, Kaluzna M, Lindholm B, Pawlaczyk K, Oko A.

Blood Purif. 2015;40(2):139-45.

10.

Biological variation of cardiac troponin in stable haemodialysis patients.

Mbagaya W, Luvai A, Lopez B.

Ann Clin Biochem. 2015 Sep;52(Pt 5):562-8. doi: 10.1177/0004563215585877.

PMID:
25908838
11.

Multiple biomarkers including cardiac troponins T and I measured by high-sensitivity assays, as predictors of long-term mortality in patients with chronic renal failure who underwent dialysis.

Hickman PE, McGill D, Potter JM, Koerbin G, Apple FS, Talaulikar G.

Am J Cardiol. 2015 Jun 1;115(11):1601-6. doi: 10.1016/j.amjcard.2015.02.066.

PMID:
25851798
12.

Developing improved clinical markers to detect heart failure and chronic kidney disease.

Yoshimura M.

Circ J. 2015;79(3):522-3. doi: 10.1253/circj.CJ-15-0065. No abstract available.

13.

Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease.

Drechsler C, Kalim S, Wenger JB, Suntharalingam P, Hod T, Thadhani RI, Karumanchi SA, Wanner C, Berg AH.

Kidney Int. 2015 Jun;87(6):1201-8. doi: 10.1038/ki.2014.429.

14.

Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study.

Voroneanu L, Siriopol D, Nistor I, Apetrii M, Hogas S, Onofriescu M, Covic A.

Kidney Blood Press Res. 2014;39(6):636-47. doi: 10.1159/000368452.

15.

Mortality prediction using modern peptide biomarkers in hemodialysis patients--a comparative analysis.

Artunc F, Nowak A, Müller C, Peter A, Heyne N, Häring HU, Friedrich B.

Kidney Blood Press Res. 2014;39(6):563-72. doi: 10.1159/000368468.

16.

NT-proBNP: is it a more significant risk factor for mortality than troponin T in incident hemodialysis patients?

Oh HJ, Lee MJ, Lee HS, Park JT, Han SH, Yoo TH, Kim YL, Kim YS, Yang CW, Kim NH, Kang SW.

Medicine (Baltimore). 2014 Dec;93(27):e241. doi: 10.1097/MD.0000000000000241.

17.

Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.

Kim Y, Matsushita K, Sang Y, Grams ME, Skali H, Shah AM, Hoogeveen RC, Solomon SD, Ballantyne CM, Coresh J.

Am J Kidney Dis. 2015 Apr;65(4):550-8. doi: 10.1053/j.ajkd.2014.08.021.

18.

Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD.

Colbert G, Jain N, de Lemos JA, Hedayati SS.

Clin J Am Soc Nephrol. 2015 Mar 6;10(3):515-29. doi: 10.2215/CJN.03600414. Review.

19.

Impact of hemodialysis on the level of high-sensitivity cardiac troponins T in patients with end-stage renal disease.

Levi M, Bonenfant F, Brouwers FM, Farand P, Corbin F, Nguyen M.

Minerva Cardioangiol. 2015 Jun;63(3):179-86.

PMID:
25389561
20.

Characterising haemodynamic stress during haemodialysis using the extrema points analysis model.

Eldehni MT, Odudu A, McIntyre CW.

Nephron Clin Pract. 2014;128(1-2):39-44. doi: 10.1159/000359958.

PMID:
25342115
Items per page

Supplemental Content

Loading ...
Support Center